Millions of young people could miss out on effective treatments because too few take part in medical research, new data shows. Gen Z (aged 18–24) make up 8% of England’s population but only 4.4% of research participants, raising concerns that future treatments may not meet their needs.
Experts warn that most studies focus on older adults, meaning new medicines may be less safe or effective for younger people. Kirsty Blenkins of the Association for Young People’s Health said this “risks poorer outcomes and reduced trust in healthcare.”
Barriers include low awareness, privacy concerns, and a lack of youth-focused recruitment. Dr Esther Mukuka of the NIHR urged more young people to join trials, noting that even small actions — like surveys or samples — “help shape the NHS of tomorrow.”
Experts also highlight the need for more representation of women and ethnic minorities to ensure future treatments work for everyone.
